Physician profile
Avery T Jones
NPI 1770661183
$1,027.64
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $91.44 · 2021: $166 · 2022: $72.57 · 2023: $338 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $313.06 | 2023-2024 | Miebo, Xiidra, Vyzulta |
| Coopervision INC. | $174.97 | 2019-2023 | Myday Contact Lens |
| Apellis Pharmaceuticals, INC. | $121.24 | 2023 | |
| Optos, INC. | $118.49 | 2019 | |
| Alcon Vision LLC | $75.41 | 2021-2022 | |
| Allergan, INC. | $65.32 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $64.72 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.49 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $19.84 | 2021 | |
| Mallinckrodt Hospital Products INC. | $19.60 | 2020 | |
| Mallinckrodt Enterprises LLC | $18.62 | 2019 | |
| Horizon Therapeutics Plc | $13.88 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avery Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.